Cowen advises Gilead Sciences, Inc. on the sale of Spleen Tyrosine Kinase (SYK) Inhibitor Portfolio to Kronos Bio

Tombstone Gilead Kronos Transaction 2020 en
Overview

Similar Transactions

Tombstone Immunomedics Gilead EN
Tombstone hg medical nordholding en